Risk and Benefit of Oral Anticoagulants in Atrial Fibrillation

被引：0
|
作者：
Zotova, I. V. [1 ]
Zateyshchikov, D. A. [1 ]
机构：
[1] President RF, FSI Educ Sci Med Ctr, Gen Management Dept, Moscow 121356, Russia
来源：
KARDIOLOGIYA | 2011年 / 51卷 / 10期
关键词：
atrial fibrillation; indirect anticoagulants; thromboembolism; bleeding; risk stratification; CLINICAL CLASSIFICATION SCHEMES; MAJOR BLEEDING COMPLICATIONS; SOLUBLE CD40 LIGAND; WARFARIN THERAPY; STROKE RISK; VENOUS THROMBOEMBOLISM; ARTERIAL EMBOLISM; NATIONAL REGISTRY; PREDICTING STROKE; ISCHEMIC-STROKE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Thromboembolism is the main cause of death and disability of patients with atrial fibrillation. Indirect anticoagulants are effective means of primary and secondary prevention of thromboembolic complications. However in a number of patients risk associated with therapy with indirect anticoagulants might exceed potential benefit. The principle problem requiring solution in a patient with atrial fibrillation is individual comparative assessment of risk of development of thromboembolic and hemorrhagic complications. Modern stratification scales which allow solving this problem are considered in this review.
引用
收藏
页码：81 / 91
页数：11
相关论文
共 50 条
  • [21] Oral anticoagulants in older adults with atrial fibrillation
    Gwen M. Bernacki
    Richard C. Becker
    [J]. Journal of Thrombosis and Thrombolysis, 2013, 36 : 403 - 415
  • [22] Oral anticoagulants for Asian patients with atrial fibrillation
    Sabir, Ian
    Khavandi, Kaivan
    Brownrigg, Jack
    Camm, A. John
    [J]. NATURE REVIEWS CARDIOLOGY, 2014, 11 (05) : 290 - 303
  • [23] The new oral anticoagulants in atrial fibrillation: an update
    F. W. A. Verheugt
    [J]. Netherlands Heart Journal, 2013, 21 : 480 - 484
  • [24] PATTERNS OF ORAL ANTICOAGULANTS USE IN ATRIAL FIBRILLATION
    Brais, C.
    Larochelle, J.
    Turgeon, M. H.
    Tousignant, A. S.
    Blais, L.
    Perreault, S.
    Farand, P.
    Letemplier, G.
    Beauchesne, M. F.
    [J]. JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2015, 22 (01): : E90 - E95
  • [25] Direct Oral Anticoagulants and Mortality in Atrial Fibrillation
    Ellis, Martin
    Ruslan, Sergienko
    Ariel, Hammerman
    Greenberg-Dotan, Sari
    Battat, Erez
    Hamburger-Avnery, Orly
    Greenberg, Dan
    Ronen, Arbel
    [J]. BLOOD, 2018, 132
  • [26] New Oral Anticoagulants in Atrial Fibrillation Forever?
    Verheugt, Freek W. A.
    [J]. CIRCULATION, 2013, 128 (03) : 200 - 202
  • [27] Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
    Senoo, Keitaro
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2014, 39 (09) : 319 - 344
  • [28] A Review of Oral Anticoagulants in Patients with Atrial Fibrillation
    Greenspon, Arnold J.
    [J]. POSTGRADUATE MEDICINE, 2012, 124 (06) : 7 - 16
  • [29] Novel oral anticoagulants and atrial fibrillation in the elderly
    Hanon, Olivier
    [J]. GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2013, 11 : 34 - 40
  • [30] Satisfaction with oral anticoagulants in patients with atrial fibrillation
    Suarez Fernandez, Carmen
    Castilla-Guerra, Luis
    Cantero Hinojosa, Jesus
    Maria Surinach, Josep
    Acosta de Bilbao, Fernando
    Jose Tamarit, Juan
    Diaz Diaz, Jose Luis
    Luis Hernandez, Jose
    Pose, Antonio
    Montero-Perez-Barquero, Manuel
    Roquer, Jaume
    Gallego, Jaime
    Vivancos, Jose
    Maria Mostaza, Jose
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 267 - 274
12345